Risankizumab

JDD Issue Highlights | March 2022
by NEXT STEPS IN DERM TEAM on
The March 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from acne and psoriasis to Platelet Rich Plasma (PRP) for scarring alopecia and racial differences and their impact on treatment for hidradenitis suppurativa, we share this month’s issue highlights straight from the JDD Editor’s de …

Continue reading "JDD Issue Highlights | March 2022"

IL-23 Inhibitors for Psoriasis Therapeutic Cheat Sheet
IL-23 Inhibitors
by Blair Allais, MD on
Psoriasis involves a complex inflammatory cascade mediated by various cytokine effectors. Over the past fifteen years, treatment options have evolved to include biologic medications that provide targeted inhibition of various pathways. IL-23 has emerged as an important inflammatory cytokine in the pathogenesis of psoriasis. We continue our series, Therapeutic Cheat Sheet, with a closer look at IL- …

Continue reading "IL-23 Inhibitors for Psoriasis Therapeutic Cheat Sheet"